Clinical evidence guidelines in systemic lupus erythematosus: revaluation
- PMID: 30254033
- DOI: 10.1136/annrheumdis-2018-214357
Clinical evidence guidelines in systemic lupus erythematosus: revaluation
Keywords: belimumab; infections; systemic lupus erythematosus; treatment.
Conflict of interest statement
Competing interests: None declared.
Comment in
-
Response to: 'Clinical evidence guidelines in systemic lupus erythematosus: revaluation' by Scheinberg.Ann Rheum Dis. 2019 Nov;78(11):e120. doi: 10.1136/annrheumdis-2018-214385. Epub 2018 Oct 23. Ann Rheum Dis. 2019. PMID: 30352890 No abstract available.
Comment on
-
First Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus: Latin American Group for the Study of Lupus (GLADEL, Grupo Latino Americano de Estudio del Lupus)-Pan-American League of Associations of Rheumatology (PANLAR).Ann Rheum Dis. 2018 Nov;77(11):1549-1557. doi: 10.1136/annrheumdis-2018-213512. Epub 2018 Jul 25. Ann Rheum Dis. 2018. PMID: 30045853 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
